Upload
jterani
View
237
Download
0
Embed Size (px)
Citation preview
8/8/2019 1Overview of Head & Neck Tumours
1/115
ASSOC PROF DR BAHARUDIN ABDULLAH
Dept of Otorhinolaryngology-Head & Neck Surgery
School Of Medical Sciences
Universiti Sains Malaysia
ENT Head and Neck Radiology Seminar16-17 July 2010Hospital Ampang
8/8/2019 1Overview of Head & Neck Tumours
2/115
Definition:Tumours (neoplasm) is a mass of tissue formedas a result of abnormal, excessive andinappropriate proliferation of cells, the growthof which continues indefinitely and regardlessof the mechanisms which control normalcellular proliferation.
8/8/2019 1Overview of Head & Neck Tumours
3/115
Classification:Benign-a single mass, localized, symptomless, can
be excised completelyMalignant-invade surrounding tissues,spread by
lymphatics and BV to other parts of body
8/8/2019 1Overview of Head & Neck Tumours
4/115
8/8/2019 1Overview of Head & Neck Tumours
5/115
50% present beforeage 20
Midline (75%) or nearmidline (25%)Elevates onswallowing/protrusio
n of tongueSurgery
8/8/2019 1Overview of Head & Neck Tumours
6/115
Cystic mass anterior toSCM, below mandibleMay get infected
Persistence of 2nd
branchial cleftMay have small sinustract into tonsillar fossaContains cholesterolcrystals
Video
8/8/2019 1Overview of Head & Neck Tumours
7/115
Cystic swelling floor of mouth( ranula-littlefrog)Mucous extravasation from sublingual salivarygland.May extend through FOM muscles into neck-Plunging Ranula
8/8/2019 1Overview of Head & Neck Tumours
8/115
8/8/2019 1Overview of Head & Neck Tumours
9/115
8/8/2019 1Overview of Head & Neck Tumours
10/115
1) Marking2) Skin incision3)Mobilization1 ,Mobilization24) Preservation of Lingual Nerve5)Ligation of Submandibular Duct6)Specimen
http://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/marking.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/incision.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/mobilization1.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/mobilization2.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/LingualNerve.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/Duct.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/Specimen.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/Specimen.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/Duct.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/LingualNerve.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/mobilization2.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/mobilization1.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/incision.mpeghttp://d/CLINICAL_VIDEO/SubmandibularMass/SitiFarah_B370230_Pleomorphic/Operation_24Jul08/Video/marking.mpeg8/8/2019 1Overview of Head & Neck Tumours
11/115
Dr Baharudin AbdullahDr VMK BhavarajuDr Win Mar@ SalmaDr Mutum S Singh
1 Dept of ORL-HNS, School of Medical Sciences, Univ. Sains Malaysia.2 Dept of Nuclear Medicine, School of Medical Sciences, Univ. Sains Malaysia.
3 Dept of Radiology, School of Medical Sciences, Univ. Sains Malaysia.4 Dept of Pathology, School of Medical Sciences, Univ. Sains Malaysia.
International ORL Audiology Meeting 2007Rosario, Argentina
8/8/2019 1Overview of Head & Neck Tumours
12/115
A 19yr Female was referred for left sidedneck swelling just below the ear of >4 yearsdurationHistory of:
Recent increase in the swelling present
Mild pain in the swelling occasionally with noh/o radiation of painLOA & LOW present
Case Presentation
8/8/2019 1Overview of Head & Neck Tumours
13/115
No history of :Nasal discharge or blockageHearing defects or ear dischargeAny difficulty or pain while swallowingFacial asymmetry notedVoice changes
Contact with Tuberculosis patientNo other swelling over the body or any discolorationnoted
8/8/2019 1Overview of Head & Neck Tumours
14/115
Oropharynx:Bulging of the left lateral pharyngealwallNo evidence of inflammation
Nasopharynx:No obvious mass seen at fossa ofRosenmuller or at the roof
8/8/2019 1Overview of Head & Neck Tumours
15/115
8/8/2019 1Overview of Head & Neck Tumours
16/115
8/8/2019 1Overview of Head & Neck Tumours
17/115
8/8/2019 1Overview of Head & Neck Tumours
18/115
Loose stroma, psammoma body
8/8/2019 1Overview of Head & Neck Tumours
19/115
Stained with vimentin and EMA-differentiate from glioma, schwannoma
8/8/2019 1Overview of Head & Neck Tumours
20/115
Patient underwent a tumor debulking via atransparotid approach and received post operativeradiation to the residual tumorA dose of 45 Gy/25#/5 weeks delivered by a 6 MvLinear AcceleratorPost operative Irradiation is given to reduce thelocal recurrenceTo prolong the disease free survivalA dose to be delivered depend on the normal tissuetoleranceIn the present case cervical spinal cord is thelimiting factor for the radical dose of radiation to bedelivered
8/8/2019 1Overview of Head & Neck Tumours
21/115
Type 1 direct extension from intracranial tumorthrough foraminaType 2 extra cranial growth from arachnoid withinthe cranial nerve sheath
Type 3- extra cranial growth from ectopic or embryoniccell rest arachnoid without connection to skull base orcranial nerveType 4 distant metastases from intracranialmeningioma
8/8/2019 1Overview of Head & Neck Tumours
22/115
8/8/2019 1Overview of Head & Neck Tumours
23/115
1. Nasopharyngeal Carcinoma2. Laryngeal Carcinoma3. Oral cavity Cancers4. Thyroid Cancer5. Salivary Gland Cancer6. Skin Cancers of Head and Neck
7. etc. such as Ca Ear, Ca Nose and ParanasalSinuses
8/8/2019 1Overview of Head & Neck Tumours
24/115
6th most common cancer worldwideHNSCC ~ 5% all cancersSCC most common upper aerodigestive tract
malignancySmoking and alcoholManagement presents considerable functionaland aesthetic problemsMultidisciplinary approach imperative
8/8/2019 1Overview of Head & Neck Tumours
25/115
Complete HistoryPhysical examination
Endoscopic assessment of upper aerodigestivetract.Imaging studies US/CT scanBiopsyTreatment
8/8/2019 1Overview of Head & Neck Tumours
26/115
Rim enhancementCentral necrosisNodal size > 1cmObliteration of tissue planes
8/8/2019 1Overview of Head & Neck Tumours
27/115
FNAVery accurateOpen BiopsyShould be avoidedCan complicate future therapy
8/8/2019 1Overview of Head & Neck Tumours
28/115
SafeRapidInexpensivePresurgicalplanning, patient counselling.Avoids open biopsyNo evidence of tumour seeding in HAN
8/8/2019 1Overview of Head & Neck Tumours
29/115
SafeRapidInexpensive
Presurgicalplanning,patient counselling.Avoids open biopsyNo evidence of
tumour seeding inHAN
8/8/2019 1Overview of Head & Neck Tumours
30/115
Primary tumour+ cervical nodesSurgery/DXRT/ChemotherapySometimes palliationCervical neck disease reduces survival by 50%
8/8/2019 1Overview of Head & Neck Tumours
31/115
Cancers of the oral cavity are treated by primarysurgical resection. Adjuvant radiotherapy orconcurrent chemoradiation is indicated for high-riskgroup.
Tumors of the pharynx (oropharynx or hypopharynx)are treated primarily with combined chemoradiation.Laryngeal cancers are also treated with chemoradiationif the larynx is functional. However, if the tumor hasdestroyed the laryngeal skeleton, surgery may berequired to restore an adequate airway and maintainswallowing.
8/8/2019 1Overview of Head & Neck Tumours
32/115
8/8/2019 1Overview of Head & Neck Tumours
33/115
8/8/2019 1Overview of Head & Neck Tumours
34/115
Symptoms & Signs - Persistent SOM- Neck Mass (Laterally at level 2)- Nasal S&S - Nasal obstruction- Nose Bleed or Bloody discharge- etc.- Cranial Nerve 5, 6, 9, 10, 11 and 3 & 4
- Miscellaneous - Headache- Feeling lump in throat
8/8/2019 1Overview of Head & Neck Tumours
35/115
Treatment - Radiation is a major role- External- Brachy therapy
- Stereotactic Radiation or Gamma knife- Chemotherapy is an adjunctive modality- Surgery - Eradicate residual lymphnodes orprimary resectable disease- PDT- etc
8/8/2019 1Overview of Head & Neck Tumours
36/115
The WHO classification based on the degree of differentiation.Type I: keratinizing squamous cell carcinoma (SCC), similar toother head and neck cancer.Type II: nonkeratinizing carcinoma (IIa)Type III: undifferentiated carcinoma, has a typical morphologywith a prominent lymphoplasmacytic infiltrate, and is alsoreferred as lymphoepithelioma. (IIb)In endemic areas, WHO Type III accounts for more than 97%,while keratinizing SCC is more common in the Western countries(~75%).
Latent EBV infection is uniquely present in almost all NPC fromendemic regions, but absent in WHO Type I NPC from non-endemic regions.
8/8/2019 1Overview of Head & Neck Tumours
37/115
8/8/2019 1Overview of Head & Neck Tumours
38/115
Baharudin AbdullahShahid Hassan
Department of ORL-HNSSchool of Medical SciencesUniversiti Sains Malaysia
8/8/2019 1Overview of Head & Neck Tumours
39/115
Introduction
Benign, malignant skull base tumour notuncommonConventional approach for early tumors
For extensive/intracranial/recurrent tumornasopharynx difficult to approachadequate exposure for surg. control of tumour
8/8/2019 1Overview of Head & Neck Tumours
40/115
Nasopharyngeal Pathology
Total no.of case - 09
Extensive JNA - 02
Recurrent JNA - 03
Chordoma - 01
Recurrent NPC - 03
8/8/2019 1Overview of Head & Neck Tumours
41/115
Hospitals - procedure carried outHospital Universiti Sains Malaysia 07 Cases
Tg. Ampuan Afzan Hosp. Kuantan 01 Case
General Hospital K. Bharu, Kelantan 01 Case
8/8/2019 1Overview of Head & Neck Tumours
42/115
Approaches to central Skull Base
Superior TranscranialInferior TranspalatalLateral InfratemporalAnterior TransantralAnterolateral Maxillary Swing
8/8/2019 1Overview of Head & Neck Tumours
43/115
Exposure Achieved in C.S.Base
Other S.B.Approach Maxillary Swing Approach
Nasopharyngeal region In addition to C.S. BaseEustachian tube Pterygopalatine fossaParanasopharyngeal area Infratemporal fossa
Floor of the orbit if eroded
8/8/2019 1Overview of Head & Neck Tumours
44/115
JNA - Introduction
Benign but recurrent diseaseIncidence 1 in 5000 - 1 in 60 0000.5% of all Head and Neck tumorOrigin - sphenopalatine foramenTreatment - surgical resection
8/8/2019 1Overview of Head & Neck Tumours
45/115
JNA Management and Outcome
Type I & II Small one window approachType III External cervical approachType IV Combined N.surg. approachRecurrent Resection by E.C. approach
Rx.for Intracranial extension
8/8/2019 1Overview of Head & Neck Tumours
46/115
JNA Problem of Recurrence
Difficult revision surgery
Inaccessible extensionInadequate exposureAdhesion and fibrosis
Infratemporal fossa approachDifficult to performInherited complication
8/8/2019 1Overview of Head & Neck Tumours
47/115
JNA-Indication and Feasibility
Extensive or recurrent growthTumor eroding skull baseIntracranial extradural extension
Opportunity of I.M.A ligation
8/8/2019 1Overview of Head & Neck Tumours
48/115
Result - JNA
Fast and complete healingAcceptable complicationsAdequate tumour exposure
Feasible and complete excisionNo recurrence in all 05 cases
8/8/2019 1Overview of Head & Neck Tumours
49/115
NPC - Introduction
Malignant and recurrent diseaseTreatment of choice radiotherapy8% of all malignancies in H & N clinic
18% in certain racial areas like HK
8/8/2019 1Overview of Head & Neck Tumours
50/115
NPC- Management and Outcome
T1 N0 Lesion - claimed 50% cureT2 N1 Lesion - 38% 5 yrs survivalT3 N2 lesion - 15% 5yrs survival
8/8/2019 1Overview of Head & Neck Tumours
51/115
Problem of recurrent disease
Usually associated with neck gland metastasis
Radiotherapy/ chemotherapy/ BrachytherapyConcomitant therapy effective but >morbidity
Greater dosage needed will increase morbidity
8/8/2019 1Overview of Head & Neck Tumours
52/115
NPC-Indication and Prerequisite
Recurrent NPCNot eroding S.B.No neck metastasis
Tumor not > 2 cm in size
8/8/2019 1Overview of Head & Neck Tumours
53/115
Result - NPC
Avoid dose-effective radiotherapy( Expected worst side effect)Reported better prognosis
Complete excisionAcceptable complication
8/8/2019 1Overview of Head & Neck Tumours
54/115
Chordoma - Introduction
Rare malignant lesion with incidence
8/8/2019 1Overview of Head & Neck Tumours
55/115
Problem of Management
Extensive tumor on presentationSurgical resection rarely possibleRadiotherapy, dose-effect relationshipHigh dose, safety , meticulous technique
8/8/2019 1Overview of Head & Neck Tumours
56/115
Problem of Recurrence
Recurrent disease poorer prognosisLimited choice of available treatmentPalliation radiotherapy with morbiditySurgical resection a difficult procedure
8/8/2019 1Overview of Head & Neck Tumours
57/115
Chordoma-Indication andPrerequisite
History of late presentationDifficult trans -cranial approach
Erosion of clivus and S. tursicaExtradural brainstem encroachment
8/8/2019 1Overview of Head & Neck Tumours
58/115
Result - Chordoma
Tumour excision by double swing procedureCombined Ext cervical, Neurosurgical approach
Surgical resection a better prognosis
Neurosurgical excision under expert hand
8/8/2019 1Overview of Head & Neck Tumours
59/115
Maxillary SwingProcedure
8/8/2019 1Overview of Head & Neck Tumours
60/115
Instruments for the Maxillary Swing Procedure
8/8/2019 1Overview of Head & Neck Tumours
61/115
Facial incision Palatal incision
8/8/2019 1Overview of Head & Neck Tumours
62/115
Anterolateral wallMaxilla swung laterally
8/8/2019 1Overview of Head & Neck Tumours
63/115
Repair of anterior wall Repair of zygoma
8/8/2019 1Overview of Head & Neck Tumours
64/115
8/8/2019 1Overview of Head & Neck Tumours
65/115
ComplicationsEpiphora 01 case
Trismus 01 case
Palatal fistula 01 case
8/8/2019 1Overview of Head & Neck Tumours
66/115
Complications of Maxillary swing Procedure
8/8/2019 1Overview of Head & Neck Tumours
67/115
Conclusion
Offers adequate exposure of NPExcision of extensive and recurrent tumor
Combining with other approaches possibleAlternate to trans-cranial approach in chordoma
Re-radiation effects can be avoided in NPCBetter prognosis achieved in selected cases
8/8/2019 1Overview of Head & Neck Tumours
68/115
8/8/2019 1Overview of Head & Neck Tumours
69/115
Ca oropharynx Ca hypopharynx
8/8/2019 1Overview of Head & Neck Tumours
70/115
Divided into- Glottic- Supraglottic
- Sub glottic- Transglottic
8/8/2019 1Overview of Head & Neck Tumours
71/115
Management -Surgery isa major role (with orwithout laser)
RadiationCombination of Surgeryand RadiationRadiation +Chemotherapy in Organpreservation
8/8/2019 1Overview of Head & Neck Tumours
72/115
Ca Tongue 45%Ca Floor Of Mouth 25%Ca Alveolus(Upper& Lower) 20%
Ca Buccal Mucosa 7.5%Ca Palate 2.5%
8/8/2019 1Overview of Head & Neck Tumours
73/115
8/8/2019 1Overview of Head & Neck Tumours
74/115
8/8/2019 1Overview of Head & Neck Tumours
75/115
1. Well differentiated-Papillary-Follicular
-Mixed (Pap+Foll)2. Poorly differentiated-Hurthle Cell-Medullary-Anaplastic-Malignant Lymphoma
8/8/2019 1Overview of Head & Neck Tumours
76/115
I.Epithelial tumour:
A. Benign- follicular adenoma (90%), Hurtle cell adenoma (10%)B. Malignant- Papillary (80%), follicular (10%), Hurtle cell (3%),
Medullary(5%);Anaplastic(1%), squamous cell car.
II. Nonepithelial
III.Malignant lymphoma
IV.Miscellaneous e.g teratomas
V. Secondary tumours
VI.Unclassified tumours
VII. Tumour-like lesions e.g thyroiditis, thyroid cysts, hyperplasticgoitres, amyloid goitres.
8/8/2019 1Overview of Head & Neck Tumours
77/115
Commonest as a solitary thyroid nodule (10%incidence malignant; increase after 50-60 yearsof age ;males)
-cervical lymphadenopathy(20%)-rapidly enlarging goitre-pain in the neck ,stridor ,dysphagia ,
hoarseness, evidence of metastasisMajority of malignancy-euthyroidFamily history and other tumours in MEN
8/8/2019 1Overview of Head & Neck Tumours
78/115
Past history of ionising radiationFamily history of thyroid cancerHistory of previous thyroid cancer
Rapidly growing or painfulMale ptPresence of neck or distant metastasisHard, fixed nodule with vocal cord paralysis orrecurrence cystic noduleUnder age of 14 or over 65 years of age
8/8/2019 1Overview of Head & Neck Tumours
79/115
MultidisciplinarySelection of combination modalities depend onextent of disease, the prognostic factors andrisk group analysis
Treatment modalities1.Surgery2.Radioactive iodine3.External beam radiotherapy4.Thyroxine therapy5.Chemotherapy
8/8/2019 1Overview of Head & Neck Tumours
80/115
-total lobectomy -complete removal of one thyroid lobe and theisthmus-near-total thyroidectomy :total lobectomy and isthmusectomy with
removal of more than 90% contralateral lobe-total thyroidectomy : removal of both thyroid lobes and isthmus
Minimum operation for suspected or confirmed thyroid cancer istotal lobectomy on side of lesion; often, near total thyroidectomyperformed initially.
-Collar incision at least 2 cm above suprasternal notch-may needextension to facilitate neck dissection or mediastinal exploration
-Preservation of recurrent laryngeal nerves ,parathyroids, externallaryngeal nerves important
-operation include level VI dissection
8/8/2019 1Overview of Head & Neck Tumours
81/115
Major arguments proposed for total thyroidectomy:1.Presence of microscopic disease in opposite lobe(multicentricity varies between 30-70%)2.Local recurrence in opposite lobe 5-15%3.Need for radioactive iodine follow up and thyroglobulinas a tumour marker which can be used only after total
thyroidectomy4. Hypothetical small risk of anaplastic transformation of
residual thyroid tissue5. High incidence of complication in re-operative thyroidsurgery
8/8/2019 1Overview of Head & Neck Tumours
82/115
Proponents for less than total thyroidectomy :1)Complication of routine total thyroidectomy
more disastrous2)Microscopic multicentric papillary cancer has
little prognostic implication and localrecurrence in contralateral lobe less than 5%
8/8/2019 1Overview of Head & Neck Tumours
83/115
8/8/2019 1Overview of Head & Neck Tumours
84/115
8/8/2019 1Overview of Head & Neck Tumours
85/115
Malignant MixedTumorMucoepidermoid Carcinoma-High Grade-Intermediate Grade
-Low GradeAdenoid Cystic CarcinomaAdenocarcinomaOncocytic Cell Ca
Squamous Cell Ca.Undifferentiated Cell Ca
2007 ICD-9-CM Volume 1 Diagnosis CodesDiseases Of Oral Cavity, Salivary Glands, And Jaws
8/8/2019 1Overview of Head & Neck Tumours
86/115
y, y ,ICD-9-CM Diagnosis 527Diseases of the salivary glands
A non-neoplastic or neoplastic (benign or malignant) disorder involving the salivary gland.
ICD-9-CM Diagnosis 527.0 Atrophy of salivary gland
ICD-9-CM Diagnosis 527.1Hypertrophy of salivary gland
ICD-9-CM Diagnosis 527.2SialoadenitisInflammation of the parotid gland.
ICD-9-CM Diagnosis 527.3 Abscess of salivary gland
ICD-9-CM Diagnosis 527.4Fistula of salivary gland
A fistula between a salivary duct or gland and the cutaneous surface of the oral cavity.
ICD-9-CM Diagnosis 527.5SialolithiasisCalculi occurring in a salivary gland. Most salivary gland calculi occur in the submandibular gland, but can also occur in the parotidgland and in the sublingual and minor salivary glands. Presence of small calculi in the terminal salivary ducts (salivary sand), orstones (larger calculi) found in the larger ducts.
ICD-9-CM Diagnosis 527.6Mucocele of salivary gland
A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands,presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth.
ICD-9-CM Diagnosis 527.7Disturbance of salivary secretion
An oral condition in which salivary flow is reduced. Decreased salivary flow.Dry mouth. It occurs when the body is not able to make enough sa liva.Increased salivary flow.
ICD-9-CM Diagnosis 527.8Other specified diseases of the salivary glands
ICD-9-CM Diagnosis 527.9Unspecified disease of the salivary glands
A non-neoplastic or neoplastic (benign or malignant) disorder involving the salivary gland.
8/8/2019 1Overview of Head & Neck Tumours
87/115
WHO HISTOPATHOLOGICAL CLASSIFICATION
1.Adenomas2.Carcinomas3.Non-epithelial tumours4.Malignant lymphomas5.Secondary tumours6.Unclassified tumours
8/8/2019 1Overview of Head & Neck Tumours
88/115
8/8/2019 1Overview of Head & Neck Tumours
89/115
3 % of head and neck malignant tumours80 % occur in parotid gland10 % occur in the submandibular gland
10 % occur in sublingual gland and the minorsalivary glandsBenign tumors are more common
8/8/2019 1Overview of Head & Neck Tumours
90/115
Sublingual 70%Submandibular 40%Parotid 20 %
8/8/2019 1Overview of Head & Neck Tumours
91/115
BenignPleomorphic adenoma 80%Monomorphic adenoma
AdenolymphomaOxyphil adenoma(oncocytoma)Others
8/8/2019 1Overview of Head & Neck Tumours
92/115
MalignantMucopidermoidAdenoid cysticAcinic cell caAdenoca
8/8/2019 1Overview of Head & Neck Tumours
93/115
MalignantEpidermoidCa in pleomorphic adenomaRare: squamous cell, undifferentiated ca
8/8/2019 1Overview of Head & Neck Tumours
94/115
40% of malignant tumours at all salivary types
Infiltrative growth
Marked tendency to invade nerve8% with Lnpathy at presentationMets-lungs
8/8/2019 1Overview of Head & Neck Tumours
95/115
Most common childhood tumour4-9 % of malignant tumoursComposed of epidermoid and mucous cells
Solid or cystic90% or more tumour cells-high grade40 % LNpathy
8/8/2019 1Overview of Head & Neck Tumours
96/115
2.5-4% of tumorsPredominantly parotidFrom terminal tubular intercalated duct
Maybe bilateralSlow growingLocal recurrence and mets after a long disease
free interval are common
8/8/2019 1Overview of Head & Neck Tumours
97/115
Malignant lymphomaUnclassified tumors
8/8/2019 1Overview of Head & Neck Tumours
98/115
1-3% in Head & Neck CancerSquamous cell carcinomaLymphoreticular tumors
EthesioneuroblastomaMinor salivary gland tumorsMelanoma
8/8/2019 1Overview of Head & Neck Tumours
99/115
Cause & Risk Factors - Environment- nickel refiners- petroleum refiners
- woodworkers- leather workers- textile workers
- Genetic
8/8/2019 1Overview of Head & Neck Tumours
100/115
Symptoms & Signs- Nasal obstruction- Bloody discharge
- Facial pain- Foul smell
8/8/2019 1Overview of Head & Neck Tumours
101/115
61st Annual General and Scientific Meetingof the NZ Society of ORL-HNS
8/8/2019 1Overview of Head & Neck Tumours
102/115
Baharudin Abdullah 1
Shamim Ahmed Khan1
Hillol K Pal 21 Dept of ORL-HNS, School of Medical Sciences, Universiti
Science Malaysia, 16150 K.Kerian, Kelantan, Malaysia2 Dept of Neuroscience, School of Medical Sciences,
Universiti Science Malaysia, 16150 K.Kerian, Kelantan,Malaysia
8/8/2019 1Overview of Head & Neck Tumours
103/115
A 50 years old man presented with a left sidednasal block and epistaxis for one year.A rigid endocopic examination showed a
whitish-reddish mass occupying the whole ofthe left nasal cavity.The mass was friable and bled on touch.
8/8/2019 1Overview of Head & Neck Tumours
104/115
The CT scan of paranasalsinus showed a largemass occupying the entireleft nasal cavityExtension into the leftmaxillary sinus anddestruction of the medialwall of the maxilla.
The mass was in contactwith the cribriform plate.
8/8/2019 1Overview of Head & Neck Tumours
105/115
There was also mildlateral bowing of theleft lamina papyraceaNo extension into theleft orbit was noted.There was noeffacement orasymmetry of fossa ofRosenmullar noted.
8/8/2019 1Overview of Head & Neck Tumours
106/115
A biopsy was taken from the intranasal mass.However, profuse bleeding occurred after thebiopsy which required nasal packing for 3
days.The biopsy showed an undifferentiatedcarcinoma.
8/8/2019 1Overview of Head & Neck Tumours
107/115
The tumor at the leftnasal cavity andadjacent to theanterior skull base/orbit was resectedusing an ultrasonicaspirator set at a
high frequencymode of 100 Hertz.
8/8/2019 1Overview of Head & Neck Tumours
108/115
The tip of the Dissectronultrasonic aspirator(Satelec Medical,Bordeaux, France) wascalibrated with the
Omnisight Image GuidedSystem (Radionics,Burlington,Massachusetts)Precise removal could be
performed without injuryof other structures at theskull base or the orbitalregion.
8/8/2019 1Overview of Head & Neck Tumours
109/115
The patient recovered well postoperatively.His hemoglobin remained between eleven totwelve g/dL.
He didnt require any blood transfusion or anyhematinics supplement.He did not have any CSF leak or any visualimpairment.
8/8/2019 1Overview of Head & Neck Tumours
110/115
8/8/2019 1Overview of Head & Neck Tumours
111/115
Apply ultrasonic energyThe piezo electricityapplied to thesonotrode creates on
the target cells a linearvibration effect 30,000times a secondAchievingfragmentationthrough a mechanicalaction.
8/8/2019 1Overview of Head & Neck Tumours
112/115
FragmentationThe simultaneoususe of an irrigation
fluid begins toinduce theselectivity of thetarget cells.
8/8/2019 1Overview of Head & Neck Tumours
113/115
Generate selectivitySelective exeresis isachieved byintracellular cavitation
as a result of thecavitation in aqueoustissues and of thedifferent elasticity of thesurrounding tissues(nerves, blood vessels,tumor tissue).
8/8/2019 1Overview of Head & Neck Tumours
114/115
Aspirate the tissuesThe fragmentedtissues suspended in
the irrigation fluidare sucked up,leaving thesurrounding
structures intact.
8/8/2019 1Overview of Head & Neck Tumours
115/115
ENT Head and Neck Radiology Seminar16-17 July 2010
Hospital Ampang